logo

FDA Calendar

Share
Company Name Roche Holding AG
Drug Name Risdiplam (NDA)
Event Name FDA decision on risdiplam for spinal muscular atrophy
Event Date 05/24/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar

>